as on January 10, 2026 at 2:29 am IST
Day's Low
Day's High
1.07%
Downside
2.14%
Upside
52 Week's Low
52 Week's High
18.38%
Downside
124.96%
Upside
Check Niagen Bioscience Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$539.5M
EPS (TTM)
0.18
Dividend Yield
0.00%
PE Ratio (TTM)
28.17
Industry PE ratio
0PEG Ratio
0Return On Equity TTM
38.90%
Track how Niagen Bioscience Inc P/E has moved over time to understand its valuation trends.
Niagen Bioscience Inc in the last 5 years
Lowest (60.68x)
September 30, 2025
Industry (0.00x)
January 10, 2026
Today (28.17x)
January 10, 2026
Highest (77.34x)
March 31, 2025
Today’s Price to Earnings Ratio: 28.17x
Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $539.5M | NA | 28.17 | 16.38% | |
| BUY | $52.8B | 171.57% | 1248.12 | 1.36% | |
| BUY | $120.4B | 95.72% | 33.01 | 31.35% | |
| NA | $35.5B | NA | 628.18 | 1.38% | |
| BUY | $84.9B | 59.72% | 19.2 | 32.13% |
Search interest for Niagen Bioscience Inc Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 3.60M → 4.57M (in $), with an average increase of 21.2% per quarter
Price Rise
![]()
In the last 3 years, NAGE stock has moved up by 232.7%
Revenue Rich
![]()
Revenue is up for the last 9 quarters, 19.49M → 33.98M (in $), with an average increase of 6.6% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 830.1% return, outperforming this stock by 597.4%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 169.7% return, outperforming this stock by 146.0%
| Organisation | Niagen Bioscience Inc |
| Headquarters | 10900 Wilshire Blvd, Los Angeles, CA, United States, 90024 |
| CEO | Mr. Robert N. Fried |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Michiko Kelley | Chief Marketing Officer |
Ms. Chu Yan | Managing Director of Asia Pacific |
Kendall Knysch | Head of Media Relations & Partnerships |
Mr. Frank Louis Jaksch Jr. | Co-Founder & Chairman |
Mr. Carlos Lopez | Senior VP & General Counsel |
Mr. James Lee | Controller |
Dr. Andrew Shao Ph.D. | Senior Vice President of Global Regulatory & Scientific Affairs |
Mr. Robert N. Fried | CEO & Director |
Mr. Ozan Pamir C.F.A. | CFO & Principal Accounting Officer |
Wesley Yu | Vice President of Finance |
Niagen Bioscience Inc share price today is $6.53 as on at the close of the market. Niagen Bioscience Inc share today touched a day high of $6.67 and a low of $6.46.
Niagen Bioscience Inc share touched a 52 week high of $14.69 on and a 52 week low of $5.33 on . Niagen Bioscience Inc stock price today i.e. is closed at $6.53,which is 55.55% down from its 52 week high and 22.51% up from its 52 week low.
Niagen Bioscience Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Niagen Bioscience Inc (NAGE) shares with as little as ₹90.123 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹901.23 in Niagen Bioscience Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Niagen Bioscience Inc share’s latest price of $6.53 as on January 10, 2026 at 2:29 am IST, you will get 1.5314 shares of Niagen Bioscience Inc. Learn more about
fractional shares .